Related Experiment Videos
[Osteodystrophy in thalassemia major]
D Bisbocci1, P Livorno, P Modina
1Dipartimento di Medicina e Oncologia Sperimentale, Ospedale S. Vito di Torino.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|October 1, 1993
Summary
Thalassemia major patients often develop bone disorders due to iron overload (siderosis) and hormone deficiencies, leading to decreased bone density. This study links increased ferritin and low hormone levels to reduced bone mineral density in these patients.
Area of Science:
- Endocrinology
- Hematology
- Bone Metabolism
Background:
- Thalassemia major is frequently associated with skeletal complications.
- The exact pathogenesis of thalassemic osteodystrophy remains unclear.
- Iron overload (siderosis) is a known complication of thalassemia major.
Purpose of the Study:
- To investigate the relationship between siderosis and thalassemic osteodystrophy.
- To assess calcium-phosphorus balance, hormone-vitamin homeostasis, and bone turnover markers.
- To evaluate bone mineral density (BMD) in patients with thalassemia major.
Main Methods:
- Cross-sectional study of 30 adult patients with thalassemia major.
- Assessed serum ferritin, calcium, phosphorus, vitamin D metabolites (25OHD3, 1.25(OH)2D3), parathyroid hormone (i-PTH), bone turnover markers (osteocalcin), sex hormones (estradiol, testosterone), and thyroid hormones (FT4).
- Measured bone mineral density (BMD) using dual-energy X-ray absorptiometry (DXA).
- Performed linear regression analysis to identify correlations.
Main Results:
- Patients exhibited significantly elevated ferritin levels.
- Significant decreases were observed in serum i-PTH, 25OHD3, 1.25(OH)2D3, osteocalcin, estradiol, testosterone, and FT4.
- All patients showed a significant net decrease in BMD.
- Positive correlations were found between BMD and FT3, testosterone, and estradiol.
- An inverse correlation was confirmed between osteocalcin and ferritin.
Conclusions:
- Thalassemic osteodystrophy results from multiple inhibitory factors on osteoblastic activity and bone formation.
- Hormonal deficits and iron overload (siderosis) significantly contribute to bone loss.
- Anemia, chronic hypoxia, and expanded red marrow further exacerbate bone disease in thalassemia major.